Swiss agribusiness giant Syngenta AG believes rival Monsanto could make another bid to acquire the company within a matter of days.
Syngenta last month rejected a Monsanto takeover offer of $45 billion as officials said the bidundervalued the company and failed to account for potential regulatory hurdles.
A Bloomberg report, however, cited sources that indicated the two companies continued to hold informal talks in subsequent weeks. The report said Syngenta retained UBS Group to monitor investors ahead of another anticipated offer in excess of 500 francs per share.
Monsanto long viewed Syngenta as a potential overseas takeover target, which would allow the St. Louis company to execute a corporate inversion and avoid U.S. corporate taxes. The offer earlier this year came amid lagging Syngenta stock prices, which the company attributed to currency and commodity volatility.
A merger would establish a massive agribusiness company with combined sales exceeding $31 billion.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas